RESUMEN
PEGylated black phosphorus nanosheets (PEG-BPNSs) have shown promising applications in biomedicine and potentially interact with the vasculature following iatrogenic exposures. Whether the exposure to PEG-BPNSs could induce toxic effects on endothelial cells that line the blood vessels remains largely unknown. Herein, we investigate the cellular response and transcriptional profiling of human umbilical vein endothelial cells (HUVECs) after the exposure to BPNSs and PEG-BPNSs. BPNSs and PEG-BPNSs induce cellular elongation and cause significant cytotoxicity to HUVECs at 0.8 µg/mL, with viabilities of 87.8% and 87.7% respectively. The transcriptome analysis indicates that BPNSs and PEG-BPNSs at 0.4 µg/mL cause marked alterations in the expression of genes associated with detection of stimulus, ion transmembrane transport and components of plasma membrane. BPNSs and PEG-BPNSs at 0.4 µg/mL decrease the transendothelial electrical resistance (TEER) across monolayers of HUVECs by 22.8% and 20.3% compared to the control, respectively. The disturbance of tight junctions (TJs) after 24 h exposure to 0.4 µg/mL BPNSs and PEG-BPNSs is indicated with the downregulated mRNA expression of zona occluden-1 (ZO-1) by respective 16.5% and 29.9%, which may be involved in the impairment of endothelial barrier integrity. Overall, the response of HUVECs to PEG-BPNSs and BPNSs has no statistical difference, suggesting that PEGylation does not attenuate the BPNSs-induced endothelial injury. This study demonstrates the detrimental effects of BPNSs and PEG-BPNSs on barrier integrity of HUVECs, contributing to our understanding on the potential toxicological mechanisms.
Asunto(s)
Fósforo , Polietilenglicoles , Humanos , Células Endoteliales de la Vena Umbilical Humana , Polietilenglicoles/toxicidad , NanoestructurasRESUMEN
Biofilms formed from the pathogenic bacteria that attach to the surfaces of biomedical devices and implantable materials result in various persistent and chronic bacterial infections, posing serious threats to human health. Compared to the elimination of matured biofilms, prevention of the formation of biofilms is expected to be a more effective way for the treatment of biofilm-associated infections. Herein, we develop a facile method for endowing diverse substrates with long-term antibiofilm property by deposition of a hybrid film composed of tannic acid/Cu ion (TA/Cu) complex and poly(ethylene glycol) (PEG). In this system, the TA/Cu complex acts as a multifunctional building block with three different roles: (i) as a versatile "glue" with universal adherent property for substrate modification, (ii) as a photothermal biocidal agent for bacterial elimination under irradiation of near-infrared (NIR) laser, and (iii) as a potent linker for immobilization of PEG with inherent antifouling property to inhibit adhesion and accumulation of bacteria. The resulted hybrid film shows negligible cytotoxicity and good histocompatibility and could prevent biofilm formation for at least 15 days in vitro and suppress bacterial infection in vivo, showing great potential for practical applications to solve the biofilm-associated problems of biomedical materials and devices.
Asunto(s)
Antibacterianos/uso terapéutico , Biopelículas/efectos de los fármacos , Incrustaciones Biológicas/prevención & control , Materiales Biocompatibles Revestidos/uso terapéutico , Cobre/uso terapéutico , Taninos/uso terapéutico , Animales , Antibacterianos/química , Antibacterianos/efectos de la radiación , Antibacterianos/toxicidad , Adhesión Bacteriana/efectos de los fármacos , Línea Celular , Materiales Biocompatibles Revestidos/química , Materiales Biocompatibles Revestidos/efectos de la radiación , Materiales Biocompatibles Revestidos/toxicidad , Cobre/química , Cobre/efectos de la radiación , Cobre/toxicidad , Escherichia coli/efectos de los fármacos , Rayos Infrarrojos , Masculino , Ratones , Pruebas de Sensibilidad Microbiana , Terapia Fototérmica , Polietilenglicoles/química , Polietilenglicoles/toxicidad , Ratas Sprague-Dawley , Piel/patología , Infecciones Cutáneas Estafilocócicas/tratamiento farmacológico , Infecciones Cutáneas Estafilocócicas/patología , Staphylococcus aureus/efectos de los fármacos , Taninos/química , Taninos/efectos de la radiación , Taninos/toxicidadRESUMEN
Dyslipidemia is a risk factor for the pathogenesis of several diseases, such as obesity, hypertension, atherosclerosis and cardiovascular diseases. In addition to interfering with serum concentrations of cholesterol and triglycerides, hyperlipidemia is involved in oxidative stress increase and reduction of the endogenous antioxidant defenses. The fruit peel of Annona crassiflora crude extract (CEAc) and its polyphenols-rich fraction (PFAc) were investigated against hypertriglyceridemia, hypercholesterolemia and hepatic oxidative stress in Triton WR-1339-induced hyperlipidemic mice. Lipid parameters in serum, feces and liver, as well as hepatic oxidative status, and enzymatic and non-enzymatic antioxidant defense systems were analyzed. Pre-treatment with CEAc for 12 days decreased hepatic triglycerides and total cholesterol, and similar to PFAc, increased the high-density lipoprotein level. There were reductions in lipid peroxidation and protein carbonylation, as well as restoration of the glutathione defense system and total thiol content in the liver of the hyperlipidemic mice treated with PFAc. The fruit peel of A. crassiflora, a promising natural source of bioactive molecules, showed a potential lipid-lowering action and hepatoprotective activities triggered by reduction of oxidative damage and maintenance of the enzymatic and non-enzymatic antioxidant systems impaired by the hyperlipidemic state.
Asunto(s)
Annona/química , Antioxidantes/farmacología , Glutatión/metabolismo , Hiperlipidemias/tratamiento farmacológico , Hipolipemiantes/farmacología , Extractos Vegetales/farmacología , Polifenoles/farmacología , Animales , Antioxidantes/aislamiento & purificación , Antioxidantes/uso terapéutico , Colesterol/metabolismo , Frutas/química , Hiperlipidemias/inducido químicamente , Hipolipemiantes/aislamiento & purificación , Hipolipemiantes/uso terapéutico , Metabolismo de los Lípidos/efectos de los fármacos , Peroxidación de Lípido/efectos de los fármacos , Hígado/efectos de los fármacos , Masculino , Ratones Endogámicos C57BL , Estrés Oxidativo/efectos de los fármacos , Oxidorreductasas/metabolismo , Extractos Vegetales/aislamiento & purificación , Extractos Vegetales/uso terapéutico , Polietilenglicoles/toxicidad , Polifenoles/aislamiento & purificación , Polifenoles/uso terapéutico , Carbonilación Proteica/efectos de los fármacos , Triglicéridos/metabolismoRESUMEN
Bacterial biofilms are a major health concern, mainly due to their contribution to increased bacterial resistance to well-known antibiotics. The conventional treatment of biofilms represents a challenge, and frequently, eradication is not achieved with long-lasting administration of antibiotics. In this context, the present work proposes an innovative therapeutic approach that is focused on the encapsulation of N-acetyl-l-cysteine (NAC) into lipid nanoparticles (LNPs) functionalized with d-amino acids to target and disrupt bacterial biofilms. The optimized formulations presented a mean hydrodynamic diameter around 200 nm, a low polydispersity index, and a high loading capacity. These formulations were stable under storage conditions up to 6 months. In vitro biocompatibility studies showed a low cytotoxicity effect in fibroblasts and a low hemolytic activity in human red blood cells. Nevertheless, unloaded LNPs showed a higher hemolytic potential than NAC-loaded LNPs, which suggests a safer profile of the latter. The in vitro antibiofilm efficacy of the developed formulations was tested against Staphylococcus epidermidis (Gram-positive) and Pseudomonas aeruginosa (Gram-negative) mature biofilms. The results showed that the NAC-loaded LNPs were ineffective against S. epidermidis biofilms, while a significant reduction of biofilm biomass and bacterial viability in P. aeruginosa biofilms were observed. In a more complex therapeutic approach, the LNPs were further combined with moxifloxacin, revealing a beneficial effect between the LNPs and the antibiotic against P. aeruginosa biofilms. Both alone and in combination with moxifloxacin, unloaded and NAC-loaded LNPs functionalized with d-amino acids showed a great potential to reduce bacterial viability, with no significant differences in the presence or absence of NAC. However, the presence of NAC in NAC-loaded functionalized LNPs shows a safer profile than the unloaded LNPs, which is beneficial for an in vivo application. Overall, the developed formulations present a potential therapeutic approach against P. aeruginosa biofilms, alone or in combination with antibiotics.
Asunto(s)
Antibacterianos/farmacología , Biopelículas/efectos de los fármacos , Portadores de Fármacos/farmacología , Liposomas/química , Nanopartículas/química , Pseudomonas aeruginosa/efectos de los fármacos , Acetilcisteína/química , Acetilcisteína/toxicidad , Animales , Antibacterianos/química , Antibacterianos/toxicidad , Línea Celular , Portadores de Fármacos/química , Portadores de Fármacos/toxicidad , Sinergismo Farmacológico , Humanos , Liposomas/toxicidad , Ratones , Pruebas de Sensibilidad Microbiana , Moxifloxacino/farmacología , Nanopartículas/toxicidad , Palmitatos/química , Palmitatos/toxicidad , Fosfatidiletanolaminas/química , Fosfatidiletanolaminas/toxicidad , Polietilenglicoles/química , Polietilenglicoles/toxicidad , Pseudomonas aeruginosa/fisiologíaRESUMEN
The multifunctional combined nanoplatform has a wide application prospect in the synergistic treatment of cancer. Nevertheless, the traditional treatment of phototherapy is limited by the catalytic nanomaterial itself, so the effect is not satisfactory. Here, the arris of the anisotropic truncated octahedral Au (TOh Au) was coated with noble metal Pt to form a spatial separation structure, which enhanced the local surface plasmonic resonance and thus boosted the photocatalytic effect. In this system, the highly efficient photocatalysis provides a strong guarantee for oncotherapy. On the one hand, the structure of arris deposition adequately improves the efficiency of photothermal conversion, which substantially improves the effectiveness of photothermal therapy. On the other hand, in situ oxygen production of Pt ameliorates tumor hypoxia, and through the O2 self-production and sales mode, the growth and development of tumor were inhibited. Meanwhile, under the enhanced photocatalysis, more O2 were produced, which greatly evolved the treatment effect of photodynamic therapy. In the end, the addition of hyaluronic acid can specifically target osteosarcoma cells while improving the retention time and biocompatibility of the material in the body. Thus, the nanocomposite shows superexcellent synergistic enhancement of photothermal conversion efficiency and photodynamic capability in vitro and in vivo, which provides a potential possibility for osteosarcoma cure.
Asunto(s)
Antineoplásicos/uso terapéutico , Nanopartículas del Metal/uso terapéutico , Osteosarcoma/tratamiento farmacológico , Fármacos Fotosensibilizantes/uso terapéutico , Animales , Anisotropía , Antineoplásicos/química , Antineoplásicos/efectos de la radiación , Antineoplásicos/toxicidad , Catálisis/efectos de la radiación , Clorofilidas , Oro/química , Oro/toxicidad , Ácido Hialurónico/química , Ácido Hialurónico/toxicidad , Rayos Infrarrojos , Nanopartículas del Metal/química , Nanopartículas del Metal/efectos de la radiación , Nanopartículas del Metal/toxicidad , Ratones Desnudos , Osteosarcoma/metabolismo , Oxígeno/metabolismo , Fotoquimioterapia , Fármacos Fotosensibilizantes/química , Fármacos Fotosensibilizantes/efectos de la radiación , Fármacos Fotosensibilizantes/toxicidad , Terapia Fototérmica , Platino (Metal)/química , Platino (Metal)/toxicidad , Polietilenglicoles/química , Polietilenglicoles/toxicidad , Porfirinas/química , Porfirinas/efectos de la radiación , Porfirinas/uso terapéutico , Especies Reactivas de Oxígeno/metabolismo , Resonancia por Plasmón de SuperficieRESUMEN
Deposition of amyloid-ß (Aß) aggregates in the brain is a main pathological hallmark of Alzheimer's disease (AD), so inhibition of Aß aggregation has been considered as a promising strategy for AD prevention and treatment. Black phosphorus (BP) is a 2D nanomaterial with high biocompatibility and unique biodegradability, but its potential application in biomedicine suffers from the rapid degradability and unfunctionability. To overcome the drawbacks and broaden its application, we have herein designed an Aß inhibitor (LK7)-coupled and polyethylene glycol (PEG)-stabilized BP-based nanosystem. The PEGylated-LK7-BP nanosheets (PEG-LK7@BP) not only exhibited a good stability but also demonstrated a significantly enhanced inhibitory potency on Aß42 fibrillogenesis in comparison with its counterparts. This elaborately designed PEG-LK7@BP stopped the conformational transition and suppressed the fibrillization of Aß42, so it could completely rescue cultured cells from the toxicity of Aß42 (by increasing the cell viability from 72 to 100%) at 100 µg/mL. It is considered that PEG-LK7@BP could bind Aß species by enhanced electrostatic and hydrophobic interactions and thus efficiently alleviated Aß-Aß interactions. Meanwhile, the coupled LK7 on the BP surface formed a high local concentration that enhanced the affinity between the nanosystem and Aß species. Finally, PEG could improve the stability and dispersibility of the nanoplatform to make it show an increased inhibitory effect on the amyloid formation. Hence, this work proved that PEG-LK7@BP is a promising nanosystem for the development of amyloid inhibitors fighting against AD.
Asunto(s)
Péptidos beta-Amiloides/efectos de los fármacos , Nanoestructuras/química , Fragmentos de Péptidos/efectos de los fármacos , Péptidos/farmacología , Fósforo/farmacología , Polietilenglicoles/farmacología , Péptidos beta-Amiloides/toxicidad , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Humanos , Nanoestructuras/toxicidad , Fragmentos de Péptidos/toxicidad , Péptidos/química , Péptidos/toxicidad , Fósforo/química , Fósforo/toxicidad , Polietilenglicoles/química , Polietilenglicoles/toxicidad , Conformación Proteica/efectos de los fármacos , Multimerización de Proteína/efectos de los fármacosRESUMEN
In order to develop an understanding of the role of adjuvants in a popular glyphosate-based herbicide - Roundup® Concentrate Plus (RCP), on non-target organisms, the effects of pure glyphosate [N-(phosphonomethyl)-glycine], RCP and a non-ionic surfactant - polyethoxylated tallowamine (POEA) were studied in the fruit fly Drosophila melanogaster. Acute exposure to sub-lethal concentrations of RCP (15⯵g/mL) and POEA (45⯵g/mL) reduced (pâ¯<â¯0.001) lifespan of female flies compared to untreated controls or glyphosate (100⯵g/mL). Negative geotaxis responses in female flies were reduced (pâ¯<â¯0.05) following acute exposure to sub-lethal concentrations of RCP and POEA whereas glyphosate did not significantly affect this response compared to untreated flies. Acute exposure to sub-lethal concentrations of RCP and POEA elevated (pâ¯<â¯0.05) protein carbonyl levels while markedly (pâ¯<â¯0.01) inhibiting carbonyl reductase activity whereas glyphosate treatment did not significantly affect protein carbonyl levels or carbonyl reductase activity. Fecundity was reduced (pâ¯<â¯0.05) following exposure to sub-lethal concentrations of RCP and POEA whereas glyphosate did not affect fecundity. In vitro treatment of ovarian stem sheath (OSS) cells with sub-lethal concentrations of RCP and POEA revealed decreased cell viability and enhanced caspase activity indicative of pro-apoptotic processes after 48â¯h compared to untreated controls. Glyphosate however was non-toxic at the concentration used. The results suggest that RCP and the surfactant POEA are more toxic than pure glyphosate and inhibit fecundity in Drosophila by impairing cell viability through enhanced apoptosis.
Asunto(s)
Adyuvantes Farmacéuticos/toxicidad , Drosophila melanogaster/efectos de los fármacos , Herbicidas/toxicidad , Polietilenglicoles/toxicidad , Tensoactivos/toxicidad , Animales , Apoptosis/efectos de los fármacos , Línea Celular , Drosophila melanogaster/fisiología , Femenino , Fertilidad/efectos de los fármacos , Glicina/análogos & derivados , Glicina/toxicidad , Longevidad/efectos de los fármacos , GlifosatoRESUMEN
It is important to control immediate hemorrhage and prevent infection simultaneously in the wound management. However, most of hemostatic materials are associated with low efficiency of hemostasis, poor biocompatibility and lack of antimicrobial properties. A kind of starch-based macroporous sponges (KR-Sps) immobilized covalently with antimicrobial peptide KR12 using highly efficient thiol-ene photo click reaction were developed. The physical properties of these sponges could be fine-tuned by varying the ratio of modified starch/HS-PEG-SH and the polymer concentration. The in vitro and vivo results demonstrated that KR-Sps induced thrombosis, shortened clotting time and reduced the blood loss at bleeding site. Besides, KR12 immobilized sponge exhibited inherent antimicrobial properties against Gram (+) and (-) bacteria and methicillin-resistant Staphylococcus aureus (MRSA), which could maintain at least 5 days. Therefore, KR-Sps were believed to be an excellent candidate as hemostatic and antimicrobial product for the intraoperative wound management.
Asunto(s)
Antibacterianos/farmacología , Péptidos Catiónicos Antimicrobianos/farmacología , Hemostáticos/farmacología , Proteínas Inmovilizadas/farmacología , Almidón/química , Tapones Quirúrgicos de Gaza , Animales , Antibacterianos/química , Antibacterianos/toxicidad , Péptidos Catiónicos Antimicrobianos/química , Péptidos Catiónicos Antimicrobianos/toxicidad , Materiales Biocompatibles/química , Materiales Biocompatibles/farmacología , Materiales Biocompatibles/toxicidad , Escherichia coli/efectos de los fármacos , Hemostáticos/química , Hemostáticos/toxicidad , Proteínas Inmovilizadas/química , Proteínas Inmovilizadas/toxicidad , Masculino , Staphylococcus aureus Resistente a Meticilina/efectos de los fármacos , Ratones , Pruebas de Sensibilidad Microbiana , Polietilenglicoles/química , Polietilenglicoles/toxicidad , Porosidad , Ratas Sprague-Dawley , Solanum tuberosum/química , Staphylococcus aureus/efectos de los fármacos , Staphylococcus epidermidis/efectos de los fármacos , Almidón/toxicidadRESUMEN
BAY 94-9027 (Jivi) is a site-specifically PEGylated human B-domain-deleted (BDD) recombinant factor VIII (FVIII), with a 60 kDa branched PEG molecule attached. The nonclinical safety of BAY 94-9027 was evaluated in a toxicology program that included 2 weeks intravenous (IV) toxicity studies in rats and rabbits, a juvenile toxicity study in rats as well as a 26-week chronic study in rats. Doses of 75, 750, or 2250 IU/kg given every other day for 2 weeks did not elicit any findings related to BAY 94-9027. Specifically, no thrombus formation or histological changes such as cellular vacuolation were seen. In the chronic toxicity study, 40, 400, and 1200 IU/kg of BAY 94-9027 given twice weekly did not induce adverse effects related to BAY 94-9027, and no tissue vacuolation was observed. There was no PEG detected in choroid plexus or other areas of the brain, cerebrospinal fluid or in spleen or kidneys. These results were supported by toxicity studies in rats and rabbits treated with PEG 60 kDa attached to the maleimide linker (PEG-60-Mal-Cys). No findings related to PEG-60-Mal-Cys were seen. These results demonstrate the safety of BAY 94-9027 for long-term use.
Asunto(s)
Portadores de Fármacos/toxicidad , Factor VIII/toxicidad , Polietilenglicoles/toxicidad , Animales , Preparaciones de Acción Retardada , Relación Dosis-Respuesta a Droga , Portadores de Fármacos/química , Evaluación Preclínica de Medicamentos , Factor VIII/química , Infusiones Intravenosas , Masculino , Polietilenglicoles/química , Conejos , Ratas , Proteínas Recombinantes/química , Proteínas Recombinantes/toxicidad , Pruebas de ToxicidadRESUMEN
Colorless, intracytoplasmic vacuoles occur in multiple tissues in animals following repeated administration of polyethylene glycol (PEG)-conjugated molecules. The extent of vacuolation depends on physical characteristics and molecular backbone of the PEG and the dose, product, drug target/pharmacology, and duration of exposure. The collective experience gathered from multiple nonclinical toxicology studies of PEGylated biopharmaceuticals indicates that in general, PEG-related vacuolation is not associated with demonstrable cell and tissue damage or dysfunction and is reversible with sufficient duration of drug-free periods. Existing data are insufficient to predict whether nonclinical animal species differ in their sensitivity to develop PEG-associated vacuoles; however, recent data suggest that there may be species differences. Recent comprehensive reviews have addressed the basic challenges in developing PEGylated pharmaceutical products, including general reference to and description of PEG-associated tissue findings. These manuscripts have identified gaps in our current understanding of PEG-associated vacuolation, including the lack of a widely accepted standardized histological terminology and criteria to record and grade the severity of vacuolation as well as insufficient knowledge regarding the nature of the contents of these vacuoles. The goal of this article is to help address some of the gaps identified above by providing points to consider, including a pictorial review of PEG-associated microscopic findings, when evaluating and reporting the extent, severity, and significance (adversity or lack of adversity) of PEG-associated cytoplasmic vacuolation in safety assessment studies. [Box: see text].
Asunto(s)
Seguridad de Productos para el Consumidor/normas , Evaluación Preclínica de Medicamentos/normas , Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos/patología , Preparaciones Farmacéuticas/química , Formulación de Políticas , Polietilenglicoles/toxicidad , Vacuolas/ultraestructura , Animales , Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos/etiología , Especificidad de Órganos , Preparaciones Farmacéuticas/metabolismo , Polietilenglicoles/química , Polietilenglicoles/farmacocinética , Distribución Tisular , Vacuolas/efectos de los fármacos , Vacuolas/metabolismoRESUMEN
BACKGROUND: Ag2S has the characteristics of conventional quantum dot such as broad excitation spectrum, narrow emission spectrum, long fluorescence lifetime, strong anti-bleaching ability, and other optical properties. Moreover, since its fluorescence emission is located in the NIR-II region, has stronger penetrating ability for tissue. Ag2S quantum dot has strong absorption during the visible and NIR regions, it has good photothermal and photoacoustic response under certain wavelength excitation. RESULTS: 200 nm aqueous probe Ag2S@DSPE-PEG2000-FA (Ag2S@DP-FA) with good dispersibility and stability was prepared by coating hydrophobic Ag2S with the mixture of folic acid (FA) modified DSPE-PEG2000 (DP) and other polymers, it was found the probe had good fluorescent, photoacoustic and photothermal responses, and a low cell cytotoxicity at 50 µg/mL Ag concentration. Blood biochemical analysis, liver enzyme and tissue histopathological test showed that no significant influence was observed on blood and organs within 15 days after injection of the probe. In vivo and in vitro fluorescence and photoacoustic imaging of the probe further demonstrated that the Ag2S@DP-FA probe had good active targeting ability for tumor. In vivo and in vitro photothermal therapy experiments confirmed that the probe also had good ability of killing tumor by photothermal. CONCLUSIONS: Ag2S@DP-FA was a safe, integrated diagnosis and treatment probe with multi-mode imaging, photothermal therapy and active targeting ability, which had a great application prospect in the early diagnosis and treatment of tumor.
Asunto(s)
Sondas Moleculares , Imagen Óptica/métodos , Técnicas Fotoacústicas/métodos , Puntos Cuánticos , Compuestos de Plata , Células A549 , Animales , Células HeLa , Humanos , Interacciones Hidrofóbicas e Hidrofílicas , Masculino , Ratones , Ratones Endogámicos BALB C , Sondas Moleculares/química , Sondas Moleculares/toxicidad , Fosfatidiletanolaminas/química , Fosfatidiletanolaminas/toxicidad , Fototerapia , Polietilenglicoles/química , Polietilenglicoles/toxicidad , Puntos Cuánticos/química , Puntos Cuánticos/toxicidad , Compuestos de Plata/química , Compuestos de Plata/toxicidadRESUMEN
OBJECTIVES: Earlier studies demonstrated that dental resin monomers lower cellular viability and provoke oxidative stress. Reactive oxygen species (ROS) formation has a key role in triethylene glycol dimethacrylate (TEGDMA) induced adverse reactions. In the present study the effects of TEGDMA on mitochondrial functions were investigated to identify a direct molecular target for cytotoxicity. METHODS: Mitochondria were isolated from guinea pig brain. The most important bioenergetic parameters, oxygen consumption, membrane potential (ΔΨm), and ATP production were assessed. Mitochondrial H2O2 production and elimination and the NAD(P)H level reported on redox balance. RESULTS: Mitochondria were supported with respiratory substrates to be oxidized by either Complex I (CI) or Complex II (CII). ΔΨm was depolarized, respiration and ATP production was greatly diminished when applying CI substrates in the presence of TEGDMA. The same parameters remained essentially unaffected when CII substrate plus TEGDMA were applied. H2O2 production by mitochondria was significantly stimulated by TEGDMA in the presence of CI substrates. In the presence of TEGDMA mitochondrial elimination of exogenous H2O2 was impaired. When CII substrate supported the mitochondria in the absence of ADP the H2O2 generation was decreased. NADH autofluorescence results also demonstrated the inhibitory effect of TEGDMA on CI activity. SIGNIFICANCE: TEGDMA inhibits CI in the respiratory chain, which explains effects induced by TEGDMA on redox homeostasis, apoptotic and necrotic cell deaths described in previous studies. Identification of the molecular target of TEGDMA may influence the development of relevant biomaterials and may induce new therapeutic strategies to control the adverse effects of resin monomers.
Asunto(s)
Complejo I de Transporte de Electrón/efectos de los fármacos , Metabolismo Energético/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Polietilenglicoles/toxicidad , Ácidos Polimetacrílicos/toxicidad , Animales , Respiración de la Célula/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Cobayas , Peróxido de Hidrógeno/metabolismo , Mitocondrias/efectos de los fármacos , Especies Reactivas de Oxígeno/metabolismoRESUMEN
PEGylated recombinant human endostatin (M2ES) exhibited prolonged serum half-life and enhanced antitumor activity when compared with endostatin. A pre-clinical study was performed to evaluate the safety of M2ES in rats. After intravenous (IV) infusions of M2ES at a dose level of 3, 15 and 75â¯mg/kg in Sprague Dawley (SD) rats, M2ES was well tolerated in animals, with no observable changes in clinical observation, body weight, food consumption, urine analysis, hematology and serum biochemical analysis. The increase of kidney weights, and slight to severe vacuolation and necrosis of proximal tubule epithelial cells in kidney were observed in 15 and 75â¯mg/kg M2ES groups, but this adverse-effect was reversible. In summary, the major toxicity target organ of M2ES might be kidney, and the no observed adverse effect level (NOAEL) of M2ES in rats was 3â¯mg/kg in this study. These pre-clinical safety data contribute to the initiation of the ongoing clinical study.
Asunto(s)
Endostatinas/toxicidad , Polietilenglicoles/toxicidad , Animales , Anticuerpos/sangre , Evaluación Preclínica de Medicamentos , Endostatinas/química , Endostatinas/inmunología , Células Epiteliales/efectos de los fármacos , Células Epiteliales/patología , Femenino , Humanos , Túbulos Renales Proximales/citología , Masculino , Necrosis/inducido químicamente , Nivel sin Efectos Adversos Observados , Polietilenglicoles/química , Ratas Sprague-Dawley , Proteínas Recombinantes/química , Proteínas Recombinantes/inmunología , Proteínas Recombinantes/toxicidad , Pruebas de Toxicidad SubcrónicaRESUMEN
Melanoma is the deadliest type of skin cancer. CD20+ melanoma stem cells (CSCs) are pivotal for metastasis and initiation of melanoma. Therefore, selective elimination of CD20+ melanoma CSCs represents an effective treatment to eradicate melanoma. Salinomycin has emerged as an effective drug toward various CSCs. Due to its poor solubility, its therapeutic efficacy against melanoma CSCs has never been evaluated. In order to target CD20+ melanoma CSCs, we designed salinomycin-loaded lipid-polymer nanoparticles with anti-CD20 aptamers (CD20-SA-NPs). Using a single-step nanoprecipitation method, salinomycin-loaded lipid-polymer nanoparticles (SA-NPs) were prepared, then CD20-SA-NPs were obtained through conjugation of thiolated anti-CD20 aptamers to SA-NPs via a maleimide-thiol reaction. CD20-SA-NPs displayed a small size of 96.3 nm, encapsulation efficiency higher than 60% and sustained drug release ability. The uptake of CD20-SA-NPs by CD20+ melanoma CSCs was significantly higher than that of SA-NPs and salinomycin, leading to greatly enhanced cytotoxic effects in vitro, thus the IC50 values of CD20-SA-NPs were reduced to 5.7 and 2.6 µg/mL in A375 CD+20 cells and WM266-4 CD+ cells, respectively. CD20-SA-NPs showed a selective cytotoxicity toward CD20+ melanoma CSCs, as evidenced by the best therapeutic efficacy in suppressing the formation of tumor spheres and the proportion of CD20+ cells in melanoma cell lines. In mice bearing melanoma xenografts, administration of CD20-SA-NPs (salinomycin 5 mg·kg-1·d-1, iv, for 60 d) showed a superior efficacy in inhibition of melanoma growth compared with SA-NPs and salinomycin. In conclusion, CD20 is a superior target for delivering drugs to melanoma CSCs. CD20-SA-NPs display effective delivery of salinomycin to CD20+ melanoma CSCs and represent a promising treatment for melanoma.
Asunto(s)
Antineoplásicos/uso terapéutico , Portadores de Fármacos/uso terapéutico , Melanoma/tratamiento farmacológico , Nanopartículas/uso terapéutico , Células Madre Neoplásicas/efectos de los fármacos , Piranos/uso terapéutico , Animales , Antígenos CD20/química , Antineoplásicos/farmacología , Aptámeros de Nucleótidos/química , Aptámeros de Nucleótidos/metabolismo , Aptámeros de Nucleótidos/uso terapéutico , Aptámeros de Nucleótidos/toxicidad , Portadores de Fármacos/química , Portadores de Fármacos/metabolismo , Portadores de Fármacos/toxicidad , Humanos , Lecitinas/química , Lecitinas/metabolismo , Lecitinas/uso terapéutico , Lecitinas/toxicidad , Ratones Endogámicos BALB C , Nanopartículas/química , Nanopartículas/metabolismo , Nanopartículas/toxicidad , Tamaño de la Partícula , Polietilenglicoles/química , Polietilenglicoles/metabolismo , Polietilenglicoles/uso terapéutico , Polietilenglicoles/toxicidad , Piranos/farmacología , Ensayos Antitumor por Modelo de XenoinjertoRESUMEN
The aim of this study was an in vitro evaluation and comparison of the cytotoxic effects of free nisin and nisin-loaded PLA-PEG-PLA nanoparticles on gastrointestinal (AGS and KYSE-30), hepatic (HepG2), and blood (K562) cancer cell lines. To create this novel anti-cancer drug delivery system, the nanoparticles were synthesized and then loaded with nisin. Subsequently, their biocompatibility, ability to enter cells, and physicochemical properties, including formation, size, and shape, were studied using hemolysis, fluorescein isothiocyanate (FITC), Fourier transform infrared (FTIR) spectroscopy, dynamic light scattering (DLS), and scanning electron microscopy (SEM), respectively. Then, its loading efficiency and release kinetics were examined to assess the potential impact of this formulation for the nanoparticle carrier candidacy. The cytotoxicities of nisin and nisin-loaded nanoparticles were evaluated by using the MTT and Neutral Red (NR) uptake assays. Detections of the apoptotic cells were done via Ethidium Bromide (EB)/Acridine Orange (AO) staining. The FTIR spectra, SEM images, and DLS graph confirmed the formations of the nanoparticles and nisin-loaded nanoparticles with spherical, distinct, and smooth surfaces and average sizes of 100 and 200 nm, respectively. The loading efficiency of the latter nanoparticles was about 85-90%. The hemolysis test represented their non-cytotoxicities and the FITC images indicated their entrance inside the cells. An increase in the percentage of apoptotic cells was observed through EB/AO staining. These results demonstrated that nisin had a cytotoxic effect on AGS, KYSE-30, HepG2, and K562 cancer cell lines, while the cytotoxicity of nisin-loaded nanoparticles was more than that of the free nisin.
Asunto(s)
Citotoxinas/toxicidad , Nanopartículas/toxicidad , Nisina/toxicidad , Poliésteres/toxicidad , Polietilenglicoles/toxicidad , Citotoxinas/química , Citotoxinas/metabolismo , Relación Dosis-Respuesta a Droga , Portadores de Fármacos/química , Portadores de Fármacos/metabolismo , Portadores de Fármacos/toxicidad , Evaluación Preclínica de Medicamentos/métodos , Hemólisis/efectos de los fármacos , Hemólisis/fisiología , Células Hep G2 , Humanos , Células K562 , Microscopía Electrónica de Rastreo , Nanopartículas/química , Nanopartículas/metabolismo , Nisina/química , Nisina/metabolismo , Tamaño de la Partícula , Poliésteres/química , Poliésteres/metabolismo , Polietilenglicoles/química , Polietilenglicoles/metabolismo , Espectroscopía Infrarroja por Transformada de FourierRESUMEN
The mono-PEGylated recombinant human interleukin-11 (rhIL-11) was evaluated for its pharmacology and toxicology profile in non-human primates. This PEGylated IL-11 (PEG-IL11) showed a much prolonged circulating half-life of 67h in cynomolgus monkeys as compared to its un-PEGylated counterpart (~3h) through subcutaneous administration, implicating that a single injection of the recommended dose will effectively enhance thrombopoiesis in humans for a much longer period of time compared to rhIL-11 in humans (t1/2=6.9h). The toxicokinetics study of single dose and multiple doses showed that systemic exposure was positively correlated with the dosing level, implying that efficacy and toxicity were mechanism-based. A single high dose at 6.25mg/kg through subcutaneous route revealed tolerable and transient toxicity. Multiple-dose in monkeys receiving 0.3mg/kg weekly of the drug developed only mild to moderate toxicity. Major adverse events and immunogenicity in monkeys were only observed in the overdose groups. Bones were positively impacted; while reversible toxicities in heart, liver, kidney and lung observed were likely to be consequences of fluid retention. In summary, the PEG moiety on rhIL-11 did not elicit additional toxicities, and the drug under investigation was found to be well tolerated in monkeys after receiving a single effective dose of 0.1-0.3mg/kg through subcutaneous delivery, which may be allometrically scaled to a future clinical dose at 30-100µg/kg, creating a potential long acting, safer, and more convenient treatment approach based on rhIL-11.
Asunto(s)
Interleucina-11/administración & dosificación , Polietilenglicoles/administración & dosificación , Animales , Densidad Ósea/efectos de los fármacos , Densidad Ósea/fisiología , Relación Dosis-Respuesta a Droga , Evaluación Preclínica de Medicamentos/métodos , Femenino , Humanos , Inyecciones Subcutáneas , Interleucina-11/química , Interleucina-11/toxicidad , Hígado/efectos de los fármacos , Hígado/metabolismo , Pulmón/efectos de los fármacos , Pulmón/metabolismo , Macaca fascicularis , Masculino , Polietilenglicoles/química , Polietilenglicoles/toxicidad , Proteínas Recombinantes/administración & dosificación , Proteínas Recombinantes/química , Proteínas Recombinantes/toxicidadRESUMEN
Current knowledge of the benefits of nutrition supplements for eye pathologies is based largely on the use of appropriate animal models, together with defined dietary supplementation. Here, C57BL6 mice were subretinally injected with polyethylene glycol (PEG)-400, an established model of retinal degeneration with a dry age-related macular degeneration (AMD)-like phenotype, an eye pathology that lacks treatment. In response to PEG-400, markers of the complement system, angiogenesis, inflammation, gliosis, and macrophage infiltration were upregulated in both retinas and retinal pigment epithelium (RPE)/choroids, whereas dietary supplementation with a mixture based on fatty acids counteracted their upregulation. Major effects include a reduction of inflammation, in both retinas and RPE/choroids, and an inhibition of macrophage infiltration in the choroid, yet not in the retina, suggesting a targeted action through the choroidal vasculature. Histological analysis revealed a thinning of the outer nuclear layer (ONL), together with dysregulation of the epithelium layer in response to PEG-400. In addition, immunohistofluorescence demonstrated Müller cell gliosis and macrophage infiltration into subretinal tissues supporting the molecular findings. Reduced ONL thickness, gliosis, and macrophage infiltration were counteracted by the diet supplement. The present data suggest that fatty acids may represent a useful form of diet supplementation to prevent or limit the progression of dry AMD.
Asunto(s)
Coroides/metabolismo , Suplementos Dietéticos , Modelos Animales de Enfermedad , Ácidos Grasos/uso terapéutico , Retina/metabolismo , Degeneración Retiniana/prevención & control , Animales , Antiinflamatorios no Esteroideos/uso terapéutico , Biomarcadores/metabolismo , Coroides/efectos de los fármacos , Coroides/inmunología , Coroides/patología , Proteínas del Ojo/genética , Proteínas del Ojo/metabolismo , Regulación de la Expresión Génica/efectos de los fármacos , Inmunohistoquímica , Inyecciones Intraoculares , Activación de Macrófagos , Masculino , Ratones Endogámicos C57BL , Polietilenglicoles/administración & dosificación , Polietilenglicoles/toxicidad , Sustancias Protectoras/uso terapéutico , Retina/efectos de los fármacos , Retina/inmunología , Retina/patología , Degeneración Retiniana/inducido químicamente , Degeneración Retiniana/metabolismo , Degeneración Retiniana/patología , Epitelio Pigmentado de la Retina/efectos de los fármacos , Epitelio Pigmentado de la Retina/inmunología , Epitelio Pigmentado de la Retina/metabolismo , Epitelio Pigmentado de la Retina/patología , Solventes/administración & dosificación , Solventes/toxicidadRESUMEN
OBJECTIVE Pediatric high-grade gliomas (pHGGs) including diffuse intrinsic pontine gliomas (DIPGs) are primary brain tumors with high mortality and morbidity. Because of their poor brain penetrance, systemic chemotherapy regimens have failed to deliver satisfactory results; however, convection-enhanced delivery (CED) may be an alternative mode of drug delivery. Anthracyclines are potent chemotherapeutics that have been successfully delivered via CED in preclinical supratentorial glioma models. This study aims to assess the potency of anthracyclines against DIPG and pHGG cell lines in vitro and to evaluate the efficacy of CED with anthracyclines in orthotopic pontine and thalamic tumor models. METHODS The sensitivity of primary pHGG cell lines to a range of anthracyclines was tested in vitro. Preclinical CED of free doxorubicin and pegylated liposomal doxorubicin (PLD) to the brainstem and thalamus of naïve nude mice was performed. The maximum tolerated dose (MTD) was determined based on the observation of clinical symptoms, and brains were analyzed after H & E staining. Efficacy of the MTD was tested in adult glioma E98-FM-DIPG and E98-FM-thalamus models and in the HSJD-DIPG-007-Fluc primary DIPG model. RESULTS Both pHGG and DIPG cells were sensitive to anthracyclines in vitro. Doxorubicin was selected for further preclinical evaluation. Convection-enhanced delivery of the MTD of free doxorubicin and PLD in the pons was 0.02 mg/ml, and the dose tolerated in the thalamus was 10 times higher (0.2 mg/ml). Free doxorubicin or PLD via CED was ineffective against E98-FM-DIPG or HSJD-DIPG-007-Fluc in the brainstem; however, when applied in the thalamus, 0.2 mg/ml of PLD slowed down tumor growth and increased survival in a subset of animals with small tumors. CONCLUSIONS Local delivery of doxorubicin to the brainstem causes severe toxicity, even at doxorubicin concentrations that are safe in the thalamus. As a consequence, the authors could not establish a therapeutic window for treating orthotopic brainstem tumors in mice. For tumors in the thalamus, therapeutic concentrations to slow down tumor growth could be reached. These data suggest that anatomical location determines the severity of toxicity after local delivery of therapeutic agents and that caution should be used when translating data from supratentorial CED studies to treat infratentorial tumors.
Asunto(s)
Antibióticos Antineoplásicos/administración & dosificación , Neoplasias Encefálicas/tratamiento farmacológico , Neoplasias del Tronco Encefálico/tratamiento farmacológico , Doxorrubicina/análogos & derivados , Glioma/tratamiento farmacológico , Puente , Tálamo , Animales , Antibióticos Antineoplásicos/toxicidad , Neoplasias Encefálicas/patología , Neoplasias del Tronco Encefálico/patología , Células Cultivadas , Niño , Convección , Relación Dosis-Respuesta a Droga , Doxorrubicina/administración & dosificación , Doxorrubicina/toxicidad , Sistemas de Liberación de Medicamentos , Evaluación Preclínica de Medicamentos , Femenino , Glioma/patología , Humanos , Ratones Desnudos , Ratones Transgénicos , Trasplante de Neoplasias , Polietilenglicoles/administración & dosificación , Polietilenglicoles/toxicidad , Puente/efectos de los fármacos , Puente/patología , Tálamo/efectos de los fármacos , Tálamo/patologíaRESUMEN
The surfactant mixture MON 0818 is an adjuvant in various commercial formulations of the herbicide glyphosate. Initial studies have shown that MON 0818 is more toxic to aquatic animals than the active ingredient. However, few studies have examined the effect of exposure to MON 0818 on species of mollusks, and no studies have examined the effect on gastropods. The present study investigated the effect of acute exposure (96 h) of MON 0818 to the eggs, juveniles, and adults of the file ramshorn snail (Planorbella pilsbryi). Concentrations of MON 0818 up to 9.9 mg/L did not have a significant effect on the viability of eggs (p > 0.05). Juvenile snails (50% lethal concentration [LC50] = 4.0 mg/L) were more sensitive than adult snails (LC50 = 4.9-9.1 mg/L). Oviposition was inhibited by exposure to MON 0818 (median effective concentration [EC50] = 0.4-2.0 mg/L). However, oviposition resumed when snails were removed to clean water, even after 96-h exposure to up to 4.9 mg/L of MON 0818. Exposure to a concentration ≥2.7 mg/L caused visible damage to the tentacles of adult snails, which could potentially impact chemoreception. A deterministic hazard assessment indicated that environmentally relevant concentrations of MON 0818 could pose a hazard to the deposition of eggs. However, because of the relatively short half-life of MON 0818 in aquatic systems and the ability of snails to resume oviposition following the dissipation of MON 0818, environmentally relevant concentrations of MON 0818 likely pose a de minimis risk to populations of ramshorn snails. Environ Toxicol Chem 2017;36:522-531. © 2016 SETAC.
Asunto(s)
Grasas/toxicidad , Herbicidas/química , Oviposición/efectos de los fármacos , Óvulo/efectos de los fármacos , Polietilenglicoles/toxicidad , Caracoles/efectos de los fármacos , Tensoactivos/toxicidad , Contaminantes Químicos del Agua/toxicidad , Animales , Relación Dosis-Respuesta a Droga , Grasas/química , Glicina/análogos & derivados , Glicina/química , Semivida , Dosificación Letal Mediana , Polietilenglicoles/química , Caracoles/crecimiento & desarrollo , Tensoactivos/química , Contaminantes Químicos del Agua/química , GlifosatoRESUMEN
In this study, seeds of Hyoscyamus niger were exposed to different concentrations (50-800µgmL-1) of single-walled carbon nanotubes (SWCNTs) under different levels of drought stress (0.5-1.5MPa) for 14days. Germinated seeds were subsequently allowed to grow in the same culture media for 7 more days to test the further response of the seedlings in terms of biochemical changes to the employed treatments. Seeds subjected to drought showed reduction in germination percentage, vigor and lengths of roots and shoots. However, inclusion of SWCNTs at the two lowest concentrations significantly alleviated the drought stress (up to moderate levels only)-induced reduction in germination and growth attributes. This happened due to increased water uptake, up-regulation of mechanisms involved in starch hydrolysis, and reduction in oxidative injury indices including H2O2, malondialdehyde contents and electrolyte leakage. The improved plant performance under PEG-induced drought stress was a consequence of changes in the expression of various antioxidant enzymes including SOD, POD, CAT, and APX, and also biosynthesis of proteins, phenolics, and specific metabolites such as proline. Results demonstrate that treatment by low concentrations of SWCNTs can induce tolerance in seedlings against low to moderate levels of drought through enhancing water uptake and activating plant defense system.